Skip to content

Out now: the UK pharmaceutical market report, 2026 edition. See the report

BuschPharma
Updated

UK medicines regulation briefing

A plain-English guide to how medicines are authorised, licensed and monitored in the UK, and what has changed since Brexit.

Format
PDF, approx. 45 pages
Edition
2026 edition
Delivery
Download as soon as your payment arrives
Choose a licence

This is a digital research report. It doesn't promote or supply any medicine, and nothing in it is medical, clinical, legal or investment advice.

What's included

  • Who regulates what: the MHRA, NICE and the NHS
  • Marketing authorisation routes and timelines
  • Licences for manufacturing and wholesale dealing
  • Pharmacovigilance and post-market obligations
  • The UK and EU systems compared

About this pack

Most commercial questions in pharmaceuticals eventually meet a regulatory one. This briefing explains the roles of the Medicines and Healthcare products Regulatory Agency and the other bodies involved, the main authorisation routes, and how the UK system now relates to the EU's.

This briefing is general information, not legal advice.

Scope and sources

UK legislation, regulator guidance and published decisions, with EU comparison. Not legal advice.

More regulation and compliance

Regulation and compliance

GDP and GMP compliance guide

What Good Distribution Practice and Good Manufacturing Practice expect of UK companies, and how inspections tend to go.

From £179

Regulation and compliance

Medicines advertising rules briefing

How UK law and the self-regulatory codes limit the advertising and promotion of medicines, and what that means for marketing and communications.

From £149

Your basket

Your basket is empty.

Browse packs